Editorial: Emerging anti-cancer compounds and immunomodulators for pancreatic cancer treatment

Overview of attention for article published in Frontiers in oncology, April 2024

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (69th percentile)
High Attention Score compared to outputs of the same age and source (92nd percentile)

So far, Altmetric has seen 8 X posts from 8 X users, with an upper bound of 45,295 followers.

RT @DuctalvsAcinar: Our editorial on Emerging anti-cancer compounds and immunomodulators for #PancreaticCancer co-authored with @Delgiorno…

RT @DuctalvsAcinar: Our editorial on Emerging anti-cancer compounds and immunomodulators for #PancreaticCancer co-authored with @Delgiorno…

RT @DuctalvsAcinar: Our editorial on Emerging anti-cancer compounds and immunomodulators for #PancreaticCancer co-authored with @Delgiorno…

RT @DuctalvsAcinar: Our editorial on Emerging anti-cancer compounds and immunomodulators for #PancreaticCancer co-authored with @Delgiorno…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 4 additional X posts.